Erlotinib (Tarceva)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Erlotinib (Tarceva), covering 2025-03-07 to 2025-03-07. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib. [Phase 1, Phase 2]